$VLTS Urigen Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urigen Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Urigen Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Urigen Pharmaceuticals, Inc. for free.
IRS Number: 943156660
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VLTS
Company Address: 675 HIGHWAY ONE, SUITE B-206 NORTH BRUNSWICK 08902
Phone number: 732-640-0160
Former name: MEGABIOS CORP, date of change: 1996-07-16
Former name: MEGABIOS CORP, date of change: 1996-07-16
Former name: VALENTIS INC, date of change: 1999-05-06
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Urigen Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 10,000 | 700 | 1,978,693 | 2 M to 2 M (+0.51 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 10,000 | 650 | 1,968,693 | 2 M to 2 M (+0.51 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 13,000 | 845 | 1,958,693 | 1.9 M to 2 M (+0.67 %) |
| Oct 13 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.06 | 20,000 | 1,200 | 1,945,693 | 1.9 M to 1.9 M (+1.04 %) |
| Sep 18 2009 | VLTS | Urigen Pharmaceuti ... | GOLDBERG MICHAEL M | Director | Option Exercise | J | 202,500.00 | 202,500 | 41,006,250,000 | 2,025,500 | |
| Aug 05 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.07 | 20,000 | 1,400 | 1,925,693 | 1.9 M to 1.9 M (+1.05 %) |
| Jun 15 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.08 | 1,500 | 120 | 3,138,573 | 3.1 M to 3.1 M (+0.05 %) |
| Jun 05 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.09 | 7,500 | 675 | 1,905,693 | 1.9 M to 1.9 M (+0.40 %) |
| May 29 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.09 | 7,500 | 638 | 1,898,193 | 1.9 M to 1.9 M (+0.40 %) |
| May 29 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.08 | 7,500 | 600 | 1,890,693 | 1.9 M to 1.9 M (+0.40 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Garner William J | Chief Executive Of ... | Buy | P | 0.09 | 1,000 | 90 | 18,587,340 | 18.6 M to 18.6 M (+0.01 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,137,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.09 | 1,000 | 90 | 3,136,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 18 2009 | VLTS | Urigen Pharmaceuti ... | Shmagin Martin E | Chief Financial Of ... | Buy | P | 0.08 | 1,000 | 80 | 3,135,073 | 3.1 M to 3.1 M (+0.03 %) |
| Mar 26 2009 | VLTS | Urigen Pharmaceuti ... | Parsons C. Lowell | Director | Buy | P | 0.90 | 2,500 | 2,250 | 1,883,193 | 1.9 M to 1.9 M (+0.13 %) |